Advanced Search

 

Study ID Status Title Patient Level Data
112776 Completed A randomized, double-blind, placebo-controlled, two-way crossover 7-day study to investigate the safety, tolerability, pharmacodynamics and pharmacokinetics of repeat dose inhaled GW642444 25 μg (micrograms) in children aged 5-11 years with persistent asthma. Study Listed on ClinicalStudyDataRequest.com
112792 Completed Study CR9112792, a study to assess bone mineral density changes in post-menopausal osteoporotic women following discontinuation of ronacaleret or placebo treatment in study CR9108963
112801 Completed Vaccination course in children primed and boosted with pneumococcal vaccine GSK 1024850A and in age-matched unprimed children Study Listed on ClinicalStudyDataRequest.com
112801 Completed Vaccination course in children primed and boosted with pneumococcal vaccine GSK 1024850A and in age-matched unprimed children Study Listed on ClinicalStudyDataRequest.com
112807 Completed Vaccination with the pneumococcal vaccine GSK 1024850A or Prevenar™ at approximately 4 years of age in children primed with 3 doses of GSK 1024850A vaccine or Prevenar™ and boosted with 23-valent pneumococcal plain polysaccharide vaccine Study Listed on ClinicalStudyDataRequest.com
112830 Completed Persistence of antibodies after full vaccination course with GSK Biologicals’ Menitorix or MenC conjugate vaccine, co-administered with DTPa or DTPa/Hib containing vaccine and pneumococcal conjugate vaccine, in children up to 6 years of age Study Listed on ClinicalStudyDataRequest.com
112830 Completed Persistence of antibodies after full vaccination course with GSK Biologicals’ Menitorix or MenC conjugate vaccine, co-administered with DTPa or DTPa/Hib containing vaccine and pneumococcal conjugate vaccine, in children up to 6 years of age Study Listed on ClinicalStudyDataRequest.com
112851 Completed A randomised, double-blind, placebo-controlled, 2-way crossover study to determine the efficacy of repeat inhaled doses of GW870086X on FEV1 in mild to moderate asthmatics Study Listed on ClinicalStudyDataRequest.com
112855 Completed An Open-Label, Single-Arm, Phase I Study to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration) in Patients with Fludarabine-Refractory B-cell Chronic Lymphocytic Leukemia
112861 Completed A single-blind, randomised, placebo-controlled, parallel group study to investigate safety, tolerability, pharmacokinetics and the effects on cardiac function of repeat oral doses of SB-649868 in adult and elderly healthy volunteers Study Listed on ClinicalStudyDataRequest.com
112864 Completed A randomised, double-blind, placebo-controlled 4-period cross-over study to assess the efficacy and safety of repeat dose intranasal GSK1004723 (1000µg), oral GSK835726 (10mg) and cetirizine (10mg) in the environmental challenge chamber in subjects with seasonal allergic rhinitis Study Listed on ClinicalStudyDataRequest.com
112876 Completed A population-based observational study examining the incidence of pneumonia among COPD patients using Advair®
112876_1 Completed A population-based observational study examining the incidence of pneumonia among COPD patients using Advair®
112876_2 Completed A population-based observational study examining the incidence of pneumonia among COPD patients using Advair
112876_3 Completed A population-based observational study examining the incidence of pneumonia among COPD patients using Advair
112883 Completed Cohort study to document background rates of hypertension and Liver Function Test (LFT) elevations in users of Tyrosine Kinase inhibiting drugs-Varian Oncology Database
112909 Completed Booster vaccination with pneumococcal vaccine GSK1024850A in primed children and catch-up vaccination in unprimed children Study Listed on ClinicalStudyDataRequest.com
112913 Completed Lamotrigine Pregnancy Registry (LAM05)
112914 Completed The Sumatriptan and Naratriptan Pregnancy Registry
112917 Completed GlaxoSmithKline International Bupropion Pregnancy Registry
112921 Completed Impact of immediate or delayed prophylactic antipyretic treatment on the immunogenicity, reactogenicity and safety of GlaxoSmithKline Biologicals’ pneumococcal vaccine 1024850A and the co-administered DTPa-combined vaccines Study Listed on ClinicalStudyDataRequest.com
112930 Completed An open-label, randomized, adaptive design, two-period crossover study in cancer patients to evaluate the bioequivalence of alternative formulations of lapatinib compared to the commercial tablet
112933 Completed Booster vaccination with pneumococcal vaccine GSK1024850A or Prevenar™ co-administered with Hiberix™ in children primed with the same vaccines Study Listed on ClinicalStudyDataRequest.com
112949 Completed Long-term extension study of the efficacy of the 580299 vaccine in the prevention of HPV-16 and/or HPV-18 associated cervical intraepithelial neoplasia (CIN) in Japanese women vaccinated in the primary vaccination study NCT00316693 Study Listed on ClinicalStudyDataRequest.com
112963 Completed Immunogenicity, Reactogenicity and Safety of GSK Biologicals' Quadrivalent Influenza Vaccine FLU Q-QIV (GSK2282512A) When Administered Intramuscularly to Adults 18 Years of Age and Older Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.